61 patients tot 26 patients Both 12 patients After Radiotherapy 23 patients After surgery Patients Relapsed Characteristics.

Slides:



Advertisements
Similar presentations
Oncology management of CNS tumours Neil Burnet University of Cambridge Department of Oncology & Oncology Centre, Addenbrookes Hospital ECRIC CNS study.
Advertisements

RapidArc plan verification using ArcCHECK™
10th Annual Lung Cancer Conference Radiation Oncology
Rib fracture after 177 patients with Hiroshi Onishi, Hiroshi Onishi, Rihito Tominaga, Marino, Takafumi Komiyama, Kengo University of Yamanashi,
Copyright ©2008 Accuray, Incorporated. All rights reserved E CyberKnife ® Robotic Radiosurgery System Radiosurgery System Comparisons.
IGRT Prostate – the ADHB experience Nicola Gordon Imaging Specialist RT ADHB.
TREATMENT PLANNING PHOTONS & ELECTRONS Karen P. Doppke 3/20/2007.
1 ADC Calculations Lars Ewell Radiation Oncology University of Arizona Medical Center 2/8/08 1.
Radiotherapy in prostate cancer Dr.Mina Tajvidi Radiation oncologist.
Stereotactic Body Radiation Therapy (SBRT): The optimal indication for operable tumors in inoperable patients D.Katsochi 1, S.Kosmidis 1, A.Fotopoulou.
The Health Roundtable 1-1b_HRT1215-Session_HEGI_JOHNSON_WESTMEAD_NSW Volumetric Modulated Arc Therapy for Stereotactic Body Radiotherapy in Early Lung.
Radiotherapy Planning for Esophageal Cancers Parag Sanghvi, MD, MSPH 9/12/07 Esophageal Cancer Tumor Board Part 1.
Radiotherapy for Kidney cancer
Prof Ramesh S Bilimagga President AROI Group Medical Director - HCG.
ICRU 50 & ICRU 62 Paweł Kukołowicz Holycross Cancer Centre
Conformal Therapy for Lung Cancer B. Schicker, F.J. Schwab*, U. Götz Institute of Radiotherapy and Radiation Oncology St. Vincenz-Krankenhaus Limburg *Clinic.
The external beam radiotherapy and Image-guided radiotherapy (2)
Comparison of Rectal Dose Volume Histograms for Definitive Prostate Radiotherapy Among Stereotactic Radiotherapy, IMRT, and 3D-CRT Techniques Author(s):
H Ariyaratne1,2, H Chesham2, J Pettingell2, K Sikora2, R Alonzi1,2
In vivo dosimetry Eirik Malinen Eva Stabell Bergstrand Dag Rune Olsen.
Region of Interest Analysis as a Tool for Exploring Adaptive IMRT Strategy for Cervix Cancer Patients Young-Bin Cho 1,2, Valerie Kelly 1, Karen Lim 1,2,
Dan Spratt, MD Department of Radiation Oncology Neuroendocrine Prostate Cancer: FDG-PET and Targeted Molecular Imaging.
Prostate Support Group Dr Duncan McLaren Consultant Oncologist.
Learn More At: CyberKnife Radiosurgery in the Treatment of Early and Advanced (Oligo-Metastases) Breast Cancer Sandra Vermeulen,
Prognostic Value of PET Using 18F-FDG in Hodgkin’s Disease for Posttreatment Evaluation J Nucl Med 2003; 44:1225–1231 Intern 魏敬庭.
Physics of carbon ions and principles of beam scanning G. Kraft Biophysik, GSI, Darmstadt, Germany PTCOG43 Educational Satellite Meeting: Principles of.
Purpose and Objectives: To investigate
Taipei VGH Practice Guidelines: Oncology Guidelines Index Cancer of Lung Version Table of Content StagingStaging, ManuscriptManuscript Taipei Veterans.
Taipei VGH Practice Guidelines: Oncology Guidelines Index Cancer of Oral Cavity Version Table of Content StagingStaging, Manuscript Taipei Veterans.
Department of Radiotherapy & Radiobiology, Department of Ophthalmology*, Medical University of Vienna, Austria OPTIMIZING LINAC BASED STEREOTACTIC RADIOTHERAPY.
Reducing excess imaging dose to cancer patients receiving radiotherapy Adam Schwertner, Justin Guan, Xiaofei Ying, Darrin Pelland, Ann Morris, Ryan Flynn.
 Multidisciplinary Effort › Surgery › Radiation › Systemic Rx (chemo, “drugs”)
Carmel McDerby Clatterbridge Centre for Oncology, Merseyside,UK
Addition of Chemotherapy to Preoperative Radiotherapy Improves Outcomes in Rectal Cancer Slideset on: Bosset JF, Calais G, Mineur L, et al. Enhanced tumorocidal.
Taipei VGH Practice Guidelines: Oncology Guidelines Index Cancer of Cervix Version Table of Content StagingStaging, Manuscript Taipei Veterans General.
Taipei Veterans General Hospital Practices Guidelines Radiation Oncology Lung Cancer Version
Taipei Veterans General Hospital Practices Guidelines Oncology Cervical Cancer Version VGH Survival Data as of YYYY/MM/DD Proofing on 2010/MM/DD.
Taipei Veterans General Hospital Practices Guidelines Oncology Oral Cavity Cancer Version
Treatment Chart Record of patients radiation therapy history. Must contain: History and diagnosis Rationale for treatment Treatment plan Consent Documentation.
Medical Dosimetry Presented by (Add Hospital name) in conjunction with The American Association of Medical Dosimetrists.
Dr. Malhar Patel DNB (Radiation Oncology)
Modern Radiation Oncology
The use of 4DCT images to optimize the Internal Target Volume in Radiotherapy  Nikos Giakoumakis, Brian Winey, Joseph Killoran, Tania Lingos, Laurence.
Evaluation Of RTOG Guidelines For Monte Carlo Based Lung SBRT Planning
Introduction and Objectives
Optimization of Gamma Knife Radiosurgery
Updates in Hodgkin Lymphoma
Insert tables Insert graphs Insert figure
Nat. Rev. Urol. doi: /nrurol
Improved outcome of treating locally advanced lung cancer with the use of Lattice Radiotherapy (LRT): A case report  Beatriz E. Amendola, Naipy C. Perez,
European Urology Oncology
Dosimetric Benefits and Practical Pitfalls of Daily Online Adaptive MRI-Guided Stereotactic Radiation Therapy for Pancreatic Cancer  Nancy El-Bared, MD,
Meta-Analysis of Positron Emission Tomographic and Computed Tomographic Imaging in Detecting Mediastinal Lymph Node Metastases in Nonsmall Cell Lung Cancer 
Stereotactic Ablative Radiotherapy for Centrally Located Early Stage Non–Small-Cell Lung Cancer: What We Have Learned  Joe Y. Chang, MD, PhD, Andrea Bezjak,
When is it Best to Repeat a 2-Fluoro-2-Deoxy-d-Glucose Positron Emission Tomography/Computed Tomography Scan on Patients with Non-Small Cell Lung Cancer.
Follow-Up of Patients after Stereotactic Radiation for Lung Cancer: A Primer for the Nonradiation Oncologist  Kitty Huang, MSc, MDCM, David A. Palma,
Successful immunotherapy and irradiation in a HIV-positive patient with metastatic Merkel cell carcinoma  Annett Linge, Ricarda Rauschenberg, Sophia Blum,
Cone beam computed tomography-based monitoring and management of target and organ motion during external beam radiotherapy in cervical cancer  Nina Boje.
Toxicities of Organs at Risk in the Mediastinal and Hilar Regions Following Stereotactic Body Radiotherapy for Centrally Located Lung Tumors  Shuichi.
Clinical and radiobiological evaluation of a method for planning target volume generation dependent on organ-at-risk exclusions in magnetic resonance.
Hemithoracic Radiotherapy After Extrapleural Pneumonectomy for Malignant Pleural Mesothelioma: A Dosimetric Comparison of Two Well-Described Techniques 
Rectal volume variations and estimated rectal dose during 8 weeks of image-guided radical 3D conformal external beam radiotherapy for prostate cancer 
Cone beam CT based dose calculation in the thorax region
GHG meeting at ESTRO36 May, 2017
Aisling Krishnan, Yat Man Tsang, Adéle Stewart-Lord 
Individual lymph nodes: “See it and Zap it”
Technical Innovations and Patient Support in Radiation Oncology
Given that {image} {image} Evaluate the limit: {image} Choose the correct answer from the following:
Volumetric and dosimetric comparison of two delineation guidelines for the radiation treatment of laryngeal squamous cell carcinoma  C. Bondue, S. Racadot,
Dose-Escalated Stereotactic Body Radiotherapy (SBRT) as a Salvage Treatment for Two Cases with Relapsed Peripheral Lung Cancer After Initial SBRT  Shuichi.
Presentation transcript:

61 patients tot 26 patients Both 12 patients After Radiotherapy 23 patients After surgery Patients Relapsed Characteristics

20 patients tot 3 patients Mediastinal lymphonodes 3 patients Para-aortic lymphonodes 14 patients Pelvic Lymphonodes Sites of Lymphonodes relapse

TREATMENT PLANNING PTV delineated on PET plus 3 mm margins Dose prescribed to 90% isodose - IMAT optimization - 70 Gy in 35 fractions (12 patients) Gy in 5 fractions (8 patients) TREATMENT DELIVERY 6 MEV linac Multiple coplanar and no coplanar arcs Dynamic micromultileaf 5 mm Set-up controlled by Cone-Beam CT before each treatment on enlarged nodes images

Range PSA median value 1.12 PET scan negative in 27 ptz (45%) Range PSA median value 7.39 PET scan positive in 34 ptz (55%)

PSA value= 5.65 PET choline before treatment PSA value= 1.47 CT 60 dy after treatment Prescribed dose 32.5 Gy in 5 fractions CBCT and on-line correction

12 patients TOT 1 patientsPSA value unchanged 11 patients PSA value fallen to precurrence values PSA evaluable after radiotherapy (12 ptz)